Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in Metastatic Melanoma
NCT00027586Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2001
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in melanoma, sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2001; status: completed.
02
Drugs
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00027586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027586.